Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia this week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – Shaffiq Essajee spoke during today’s plenary session about HIV prevention and treatment for children with a strong focus on the treatment side. “While we are seeing 60 […]
Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia this week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – Professor David Cooper kicked off the final opening plenary in Melbourne today with a review on antiretroviral therapy including a look at recommended drug regimens for first- […]
Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – Activists surprised Gilead corporate executives today with a “die-in” to protest the pricing of Gilead’s hepatitis C drug, Solvaldi (sofosbuvir). As Gregg Alton, Gilead’s Executive Vice-President […]
Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – Laurindo Garcia, a gay man living with HIV in the Philippines offered a moving conclusion to the opening plenary In Melbourne on Thursday, speaking to […]
Science Speaks is live-blogging from AIDS 2014 in Melbourne, Australia through the week, with updates on research, policy and insights from the 20th International AIDS Conference. MELBOURNE, AUSTRALIA – During the opening plenary today, Beatriz Grinszteijn offered insights about men with have sex with men and transgender women echoing many of the themes raised in […]
HIV
The following is a guest post by Maureen Luba Milambe, African Regional Advocacy Advisor, AVAC On Tuesday (June 8), the UN General Assembly voted overwhelmingly to […]
Tuberculosis
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]